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Abstract
Background: Autism spectrum disorders (ASD) are associated with complications of pregnancy that implicate fetal
hypoxia (FH); the excess of ASD in male gender is poorly understood. We tested the hypothesis that risk of ASD is
related to fetal hypoxia and investigated whether this effect is greater among males.
Methods: Provincial delivery records (PDR) identified the cohort of all 218,890 singleton live births in the province
of Alberta, Canada, between 01-01-98 and 12-31-04. These were followed-up for ASD via ICD-9 diagnostic codes
assigned by physician billing until 03-31-08. Maternal and obstetric risk factors, including FH determined from
blood tests of acidity (pH), were extracted from PDR. The binary FH status was missing in approximately half of
subjects. Assuming that characteristics of mothers and pregnancies would be correlated with FH, we used an
Estimation-Maximization algorithm to estimate HF-ASD association, allowing for both missing-at-random (MAR) and
specific not-missing-at-random (NMAR) mechanisms.
Results: Data indicated that there was excess risk of ASD among males who were hypoxic at birth, not materially
affected by adjustment for potential confounding due to birth year and socio-economic status: OR 1.13, 95%CI:
0.96, 1.33 (MAR assumption). Limiting analysis to full-term males, the adjusted OR under specific NMAR
assumptions spanned 95%CI of 1.0 to 1.6.
Conclusion: Our results are consistent with a weak effect of fetal hypoxia on risk of ASD among males. E-M
algorithm is an efficient and flexible tool for modeling missing data in the studied setting.
Background
The autism spectrum disorders (ASD) comprise a group
of neurodevelopmental conditions that are associated
with impaired verbal and non-verbal communication
and social interaction, and restricted and repetitive pat-
terns of behavior, which typically manifest before age of
3 years [1]. Although relatively rare[2-7], ASD can have
a devastating effect on the quality of life of entire
families and is associated with considerable societal eco-
nomic burden[8]. There is some evidence that ASD pre-
valence is on the increase[9], although it remains
unclear as to whether this increase can be completely
accounted for by changes in case definition and
improved ascertainment. While some genetic risk factors
for ASD are known [10], the potential contribution of
environmental factors has not been excluded and media-
tions involving gene-environment interactions would
contribute to the observed genetic complexity in ASD.
A recent review suggests that advanced parental age and
fetal growth restriction place children at an elevated risk
of developing ASD[11]. However, a recent meta-analysis
concluded it is premature to implicate specific preg-
nancy complications in etiology of ASD[12]. Nonethe-
less, Kolevzon et al.[11], on the basis of epidemiological
evidence, advanced a hypothesis that neonatal or fetal
hypoxia are implicated in ASD, even though hypoxia
was not measured in any of the reviewed studies.
Chronically high maternal levels of dopamine have also
been suggested by Previc[13] as the underlying cause of
ASD, which would be expected to correlate with occur-
rence of fetal hypoxia. More recently Mueller and Bale
[14] argued, based on studies of stress sensitivity in
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males are more susceptible to development of maladap-
tive stress responses associated with many neurodeve-
lopmental disorders such as ASD. They suggested that
this vulnerability is determined by sex-specific differ-
ences in placental physiology[14]. Excess of ASD among
males is well-documented[15]. If fetal hypoxia were
equally likely among boys and girls, but boys were more
susceptible to its effect on ASD risk, this would contri-
bute to explaining male predominance among ASD
patients.
Parallel line of research suggests that neonatal ence-
phalopathy caused by perinatal asphyxia/hypoxia in
i n f a n t sb o r na tt e r mi sa s s o ciated with neurological
impairment later in life[16]. Therefore, it may well be
that foetal hypoxia is simply an upstream cause of neo-
natal encephalopathy that then relates to risk of ASD.
Indeed, the most recent review of the contribution of
neonatal encephalopathy to infant neurological develop-
ment concluded that even moderate post-asphyxia neo-
natal encephalopathy appears to contribute to cognitive
and sensory-motor impairments, although heterogeneity
in published results was noted[17].
In fact, one study of 239 children who survived neona-
tal encephalopathy reported that 4.2% were diagnosed
with an ASD. This represents, after adjustment for con-
founders, about a 6-fold increase in ASD risk compared
to ASD rates among 563 children who did not have
neonatal encephalopathy (0.9%)[18]. The small sample
size here led to render results of this report vulnerable
to observing “significant” findings purely due to chance
and the 95% confidence intervals of the relative risk esti-
mate (2 to 17)[18] is extremely wide, casting doubts
about the reproducibility of the finding[19].
None of the epidemiological studies conducted to date
studied direct effects of hypoxia at birth on ASD. There-
fore, we tested, in a population-based birth cohort, the
hypothesis that risk of ASD is related to fetal hypoxia
and investigated whether this effect is greater among
males.
Methods
Record linkage
This cohort and analysis of association of perinatal risk
factors with risk of ASD are described elsewhere, with-
out consideration of fetal hypoxia[20], defined as fetal
scalp pH < 7.25, or umbilical artery pH < 7.20, or
venous pH < 7.28. Delivery records held by the Alberta
Perinatal Health Program (APHP) identified the cohort
of singleton live births in the province of Alberta,
Canada, between January 1, 1998 and December 31,
2004. The APHP provided information regarding rele-
vant ante- and peri-natal risk factors. Information on
the risk factors was collected on admission to hospital
for delivery, as part of routine clinical care. They are con-
sidered to be accurate and any internal inconsistency in
the records is scrutinized by APHP; if apparent error in
the delivery records cannot be resolved, APHP records a
missing value for a given variable. The unique Personal
Health Number (PHN) of mother and child along with
child’s gender and date of birth in APHP file were used
to follow-up the cohort through records held by the
Alberta Health and Wellness (AHW). In the universal
healthcare insurance system of Alberta, all residents are
served by physicians who bill the government for their
services, linked to specific diagnostic codes, International
Classification of Diseases 9
th edition (ICD-9). Children
matched in APHP file to AHW records were followed-up
by the investigators until March 31, 2008 for (a) ICD-9
codes indicating ASD (299.0 or 299.8) listed with the
physician billing record, (b) child’s residency and mortal-
ity (in a given fiscal year ending on March 31) and (c)
mothers’ socioeconomic status. Outcome was defined
using most liberal definition from our previous work: at
least one ASD claim by any physician because such case
definition showed good sensitivity and specificity and did
not affect associations between studied risk factors and
ASD[20]. Such case definition for ASD is analogous to
the one used in another, very similar Canadian study,
where it was shown to have acceptable sensitivity and
specificity relative to gold standard diagnostic assessment
in a specialty clinic[21]. Study protocol was approved by
the University of Alberta Health Ethics Research Board
and the custodians of the data.
Statistics
Causal model considered in this paper is shown in
Figure 1. Our hypothesis is that ASD (Y) is caused by
fetal hypoxia (X). Birth year and socio-economic status
(W) are treated as confounders (as is fetal gender unless
the effect modification by gender is tested), because
there is little reason to suspect that such broad proxies
for trends in health (social-economic status) and chance
Fetal Hypoxia
(X)
Autism 
Spectrum 
Disorders
(Y)
Confounders
(W)
Distal Causes 
and/or 
Correlates of X
(Z)
Figure 1 The hypothesized relationship between birth
complications and maternal factors (Z), fetal hypoxia (X), sex,
socio-economic class and birth cohort (W), and autism
spectrum disorders (Y) (when stratified on sex, W is just socio-
economic class and birth cohort); bold font denotes a vector.
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dents of fetal hypoxia without also being associated with
risk of ASD. We make a very strong assumption that all
other covariates (Z) are assumed to be correlated with
ASD through fetal hypoxia, but relax it when we test
the notion that prematurity can also have a direct effect
o nt h er i s ko fA S D .O u rj u s t i f ication for this approach
is that we focus on testing a specific well-justified
hypothesis. In most of the analyses, unless otherwise
indicated, covariates Z include maternal age (≤ 25, 25- ≤
30, 30- ≤ 35, >35 years), maternal weight (>91 kg or <
45 kg), maternal height < 152 cm, pre-pregnancy dia-
betes, gestational diabetes, bleeding (< 20 and/or > 20
weeks), cigarette smoking (any), poor weight gain (26-36
weeks < 0.5 kg/week), parity (0, 1, 2, 3, ≥4), pre-eclamp-
sia, presentation (cephalic or breech/shoulder), type of
labor (spontaneous, induced, no labor/C-section), gesta-
tional age (< 37,≥37 weeks), birth weight (< 2.5, 2.5-4.5, >
4 . 5k g ) ,A p g a ra t1a n d5m i n( <7 ) .Al o g i s t i cr e g r e s s i o n
model was fitted to data relating odds of ASD to fetal
hypoxia, to estimate odds ratios (ORs) and associated
95% confidence intervals (CIs).
Fetal hypoxia status, the binary exposure variable of
interest (X), was missing in approximately one half of
our study subjects. Based on the notion that some vari-
ables (Zs) including characteristics of mothers and preg-
nancies would be correlated with the exposure X, we
used an EM algorithm[22] to tackle the estimation pro-
blem of the association between fetal hypoxia (X) and
A S D( Y ) ,i nt h ep r e s e n c eo fm i s s i n gv a l u e si nX .T h e
basic idea of the EM algorithm is to use subjects’ char-
acteristics Zs and the outcome Y to model X using the
subjects with observed values of X. With the model for
X with Zs and Y, we can weigh the two possibilities of
t h em i s s i n gv a l u eo fX ,X=1a n dX=0 ,i nt h el i k e l i -
hood function for maximum-likelihood statistical infer-
ence on parameters. Since the model for X with Zs and
Y contains the parameters of interest, the weighted like-
lihood function can be iteratively maximized: estimating
the weights using the current parameter estimates; and
constructing the weighted likelihood function, which
can then be maximized to update the parameter esti-
mates. We initially make an assumption that, given Z
and Y, missingness of X occurs at random: the missing-
at-random (MAR) assumption, which assumes random
missing conditioned on Z and Y. Under the MAR con-
ditioned on Z and Y, using those who have X for mod-
eling X with Z and Y is valid. It is reasonable to doubt
the validity of MAR assumption in this situation, if we
consider the possibility that the likelihood of X = 1 is
systematically higher for a given Z among those that
were tested for fetal hypoxia. For example, clinicians can
consider factors other than those measured as Zs in
ordering test for fetal hypoxia, such that their suspicion
of a positive result, over and beyond what Zs suggest, is
elevated before the test is performed. If this were
the case, then missingness in X is not at random (not-
missing-at-random, NMAR). To consider the NMAR
case, we introduce (0 ≤ r ≤ 1), the ratio of expected
probabilities of having hypoxia in X missing group and
non-missing group for a given set of Zs. Given informa-
tion from Zs, setting = 1 means we assume MAR. Any
case with < 1 amounts to postulating a special case of
NMAR. There is no data on how much smaller than 1 r
should be in our particular setting. Such values can arise
from separate experiments (not possible in our situa-
tion), or sensible guesses of values of r can be made for
the purposes of sensitivity analysis (route we followed);
yet another approach is to follow fully Bayesian
paradigm and place a prior on r. It is not possible to
optimize r from our data using EM algorithm. We con-
sidered in sensitivity analyses a range of r spanning
values consistent with excellent (r = 0.1) to moderate
(r = 0.7) additional clinical judgment indicating the like-
lihood of positive test, over and beyond Zs. Note that
r = 0.5 suggests that those not tested are only at 50%
risk of hypoxia (given Zs) compared to those who were
tested: this is consistent with the notion of predictive
ability of the clinical judgment, beyond Zs, that the
hypoxia test is positive. As we shall see below (Table 1),
intensive testing for hypoxia is associated with a factor
of 2-5 increase in detecting hypoxia, which gives strong
evidence that testing is ordered only on strong suspicion
of hypoxia and that r is in the range of 0.5 or smaller.
All EM algorithms used in this paper converged within
250 iterations. Mathematical details are given in the
Additional File 1 and sketch of SAS (SAS Institute,
Cary, NC) code required to implement the method is
given in Additional File 2. Schematic presentation of
EM algorithm we implemented is given in Figure 2.
Results
There were 273,343 singleton live births in Alberta
according to APHP records between 1998 and 2004,
among whom 25,970 children could not be identified by
AHW and 28,421 either died, or lost residence during
follow-up; a further 62 had missing gender, leaving
218,890 children for analysis. There were no systematic
differences on observable data among births that were
included and excluded (details not shown). In 48%
(105,636/218,890) of births, fetal hypoxia tests via blood
pH were performed. In a minority of births multiple
tests were performed (Table 1). A total of 17,083 tests
(14%) of the 120,836 that were preformed satisfied our
definition of fetal hypoxia: positive on at least one of the
(multiple) tests. Umbilical arterial blood pH was the
m o s tc o m m o nt e s tu s e de i t h e ro ni t so w n( n=7 5 , 7 7 5 )
or in combination with venous blood pH (n = 41,245).
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on the same neonate. However, overall prevalence of
fetal hypoxia among those tested appeared to be similar
whether all tests were required to be congruent (10%)
or only one had to be positive (14%). Measurement of
fetal scalp pH, although relatively infrequent, appears to
be associated with elevated likelihood of the overall
positive test result, perhaps because not of the inherent
superior sensitivity of the test, but because it is adminis-
tered only when there is considerable suspicion that the
fetus may be hypoxic. There were 200,557 full-terms
births in the cohort and gestational age at birth was
missing for 444 neonates. 1,011 of full-terms neonates
were diagnosed with ASD during the follow-up.
T a b l e2s u m m a r i z e sd a t ao nA S Da n dm e a s u r e so f
fetal hypoxia as observed for births of all gestational
ages. Among the subgroup of 17,083 infants classified as
hypoxic, 113 were diagnosed with ASD during the fol-
low-up (0.66%). The observed rate of ASD was slightly
lower among 88,553 infants who tested negative for fetal
hypoxia (530 ASD cases, 0.60%) and much lower among
subjects 113,254 whose fetal hypoxia status was
unknown, that is mostly not tested (495 ASD cases,
0.44%). The observed rate of ASD was the highest
among males who were hypoxic at birth (100 ASD
cases, 1.10%). Males who were tested and did not appear
to be hypoxic at birth had a slightly lower observed rate
of ASD (452 ASD cases, 0.99%), but males who were
not tested for hypoxia certainly had a reduced observed
rate of ASD compared to those males who were tested
(400 ASD cases, 0.70%). The observed rates of ASD
among female children did not vary with measures of
fetal hypoxia (0.16% among hypoxic vs. 0.18% among
non-hypoxic) and was much lower than among males
(1.10% among hypoxic vs. 0.99% among non-hypoxic).
Among full-term births the pattern of observed rates
is similar to that seem among all births in Table 2. The
observed ASD rate among full-terms births was higher
among those who tested positive for hypoxia (0.62%, 96/
15,557) compared to those who tested negative for
hypoxia (0.58%, 557/95,352). The test for hypoxia was
not performed among 105,205 members of this sub-
cohort who had an even lower observed rate of ASD
(454, 0.43% affected). 480 of 49,165 full-term male births
with data on hypoxia were diagnosed with ASD during
the follow-up (observed rate 0.98%). Among 8,286 males
hypoxic at birth, the observed rate of ASD was 1.03%
(85 cases), but among males not hypoxic at birth the
observed rate of ASD was slightly lower: 0.97% (395
cases). In this male sub-cohort, when information on
hypoxia was missing, the observed rate of ASD was even
lower 0.69% (364 cases). 77 of 46,187 full-term female
births with data on hypoxia were diagnosed with ASD
during the follow-up (observed rate 0.17%). Among
7,271 females hypoxic at birth, the observed rate of ASD
was 0.15% (11 cases), but among females not hypoxic at
birth the observed rate of ASD was higher: 0.17% (66
cases). In this female sub-cohort, when information on
hypoxia was missing, the observed rate of ASD was the
same as among girls who tested as not hypoxic at birth:
0.17% (90 cases).
We will next examine ASD rate modeled using E-M
algorithm among births of all gestational ages. Table 3
(top) presents results from E-M algorithm that modeled
the presence of fetal hypoxia for 113,254 out of 218,890
subjects and then estimated odds ratios for the associa-
tion of ASD with fetal hypoxia with and without adjust-
ment for suspected confounders (Ws) and with and
without stratification on child’s gender. In stratified ana-
lyses, strata-specific modeling of missing exposures was
performed using values of Zs specific to each gender.
There is a clear suggestion of a small excess risk of ASD
only among males who were hypoxic at birth: unad-
justed OR 1.14, 95%CI: 0.97, 1.34. This result is not
Table 1 Ascertainment of Fetal Hypoxia
1 Among Neonates
Test(s) Subjects tested All tests positive At least one test positive
Number of subjects % Number of subjects %
All three tests 26 1 4 12 46
Two tests
Fetal scalp and umbilical arterial blood pH 178 27 15 77 43
Umbilical arterial and venous pH 41,245 3,583 9 8,866 21
Fetal scalp and umbilical venous blood pH 4 0 0 0 0
One test
Fetal scalp pH 47 16 34 16 34
Umbilical arterial blood pH 75,775 7,727 10 7,727 10
Venous umbilical blood pH 3,561 385 11 385 11
Any of the three tests 120,836 11,739 10 17,083 14
1: fetal scalp pH < 7.25, umbilical artery pH < 7.20, or umbilical venous pH < 7.28.
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founding due to birth year and socio-economic status:
adjusted OR 1.13, 95%CI: 0.96, 1.33. As expected from
descriptive analyses (Table 2), there is no indication that
ASD risk among females is associated with positive test
for fetal hypoxia. The formal test of the (multiplicative)
interaction of male gender and hypoxia on the risk of
ASD did not indicate that males had a higher degree of
association between hypoxia and ASD than females: P =
0.68 for interaction OR of 0.91 (details of the model not
Observeddata
(Y,X,Z)
Initialization
1. Logistic modeling of X on Z
usingobserveddata
2. PredictP(X=1|Z)forobs.with
missingandadjustbyratior
3. Logistic modeling of Y on X
andZusingallobs.
4. UpdateP(X=1|Y,Z)formissing
obs.usingaBayesianformula
MͲStep
1. UpdatelogisticmodelofXonZ
2. Predict P(X=1|Z) for obs. with
missingandadjustbyratior
3. UpdatelogisticmodelofY on
XandZ
EͲStep
UpdateP(X=1|Y,Z)usingaBayesian
formula
Output
Parameter
Estimates
Figure 2 Flow chart of EM Algorithm (refer to Appendices for mathematical details and implementation).
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ASD etiology[23], we could not justify treating it a sole
antecedent of hypoxia and not a risk factor on its own.
To control for possible confounding effect of prematur-
ity we repeated the analysis on full-term births only
(Table 3, bottom). The results are largely consistent
with those obtained on full cohort, but suffer from loss
of precision. The observation provides some further jus-
tification in not treating Z as confounders in the bulk of
our analyses.
Lastly, we investigated the impact of specific NMAR
assumption on our results in a sub-set of full-term
male infants where the conservative analyses under the
MAR assumption indicated a possible positive associa-
tion (Table 4). There was also evidence that missing-
ness of data on hypoxia was associated with risk of
ASD in males, but not in females. Under the realistic
NMAR assumption (r from 0.1 to 0.5), it appears that
point estimate of the effect (OR) of hypoxia on risk of
ASD among males who were born at full-term
Table 2 Summary of Data on Reported Fetal Hypoxia and Diagnosis of Autism Spectrum Disorders in the Same Child
(All Gestational Ages at Birth)
1
Child’s Gender Autism Spectrum Disorders Fetal Hypoxia Total
Present
2 Absent
4 Unknown
Both Present N 113 530 495 1,138
%
3 0.66 0.60 0.44 0.52
(0.06) (0.03) (0.02) (0.02)
Total N 17,083 88,553 113,254 218,890
Male Present N 100 452 400 952
%
3 1.10 0.99 0.70 0.85
(0.11) (0.05) (0.03) (0.03)
Total N 9,109 45,594 57,257 111,960
Female Present N 13 78 95 186
%
3 0.16 0.18 0.17 0.17
(0.04) (0.02) (0.02) (0.01)
Total N 7,974 42,959 55,997 106,930
1: singletons born in Alberta 1998-2004 and followed up till March 31, 2008.
2: at least one of the three tests for fetal hypoxia is positive, i.e. fetal scalp pH < 7.25, or umbilical artery pH < 7.20, or venous pH < 7.28.
3: percentage of exposed to different states of fetal hypoxia (with standard errors).
4: excludes subjects with base pH, i.e. this reference category has pH in normal physiological range.
Table 3 Association of Fetal Hypoxia at Birth
1 and Diagnosis of Autism Spectrum Disorders
2: Results of Logistic
Regression Fitted with EM Algorithm for Handling Unknown Exposures That are Modeled From Maternal and Birth
Characteristics Under MAR Assumption (r = 1) Stratified on Child’s Gender
All gestational ages at birth
Unadjusted Adjusted
Child’s Gender Both Male Female Both
3 Male
4 Female
4
Odds ratio estimate 1.15 1.14 0.93 1.11 1.13 0.94
95% confidence interval 0.98, 1.33 0.97, 1.34 0.62, 1.40 0.95, 1.29 0.96, 1.33 0.62, 1.41
P-value 0.08 0.11 0.74 0.19 0.14 0.76
Full-term births only
Unadjusted Adjusted
Child’s Gender Both Male Female Both
3 Male
4 Female
4
Odds ratio estimate 1.11 1.10 0.92 1.07 1.09 0.93
95% confidence interval 0.94, 1.31 0.93, 1.31 0.60, 1.42 0.91, 1.34 0.91, 1.29 0.60, 1.56
P-value 0.21 0.23 0.71 0.42 0.35 0.74
1: at least one of the three tests for fetal hypoxia is positive, i.e. fetal scalp pH < 7.25, or umbilical artery pH < 7.20, or venous pH < 7.28.
2: singletons born in Alberta 1998-2004 and followed up till March 31, 2008.
3: adjusted for gender, birth year and socio-economic status.
4: adjusted for birth year and socio-economic status.
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between 1.0 and 1.6. Even if deviation from the MAR
assumption was weak (r = 0.7), the resulting change in
inference is dramatic: 95%CIs widen somewhat and
shift from 0.91-1.29 (Table 3) to 0.99-1.46 (Table 4),
while the point estimate increases from 1.09 (Table 3)
to 1.20 (Table 4).
Discussion
There are many difficulties with these data beyond miss-
ing-ness: both exposures and outcomes are suspected of
being misclassified, which would bias apparent OR esti-
mates, most likely towards the null if both misclassifica-
tion mechanisms are non-differential. Covariates from
perinatal database are known to be recorded accurately
[Ms N. Bott of APHP, personal communications]
because they use data essential to medical care, not just
billing, even though some information (such as maternal
smoking[24] used to model risk of fetal hypoxia) is
known to be collected with error. Of course error in
variables can bias our results, but we lack information
on the extent and direction of such bias. Our analysis is
also limited by small number of girls, so that our failure
to detect an association among them may simply be due
to low power. Short follow-up for some members of the
cohort born in 2004 may have introduced error due to
incomplete ASD ascertainment, since they were be only
4 at the end of follow-up, but our previous results sug-
gest that in this population peak age of diagnosis was
between ages of 3 and 4 [20], therefore our data cannot
address this potential limitation. Nonetheless, our data
are valuable because they enable the first test of associa-
tion of fetal hypoxia with risk of ASD in a population-
based birth cohort. Innovative statistical methodology
that we used to meet challenged posed by the data
s h o u l dp r o v et ob eh e l p f u lt oresearchers facing similar
complications.
We observed that males who were tested for foetal
hypoxia were more likely to develop ASD. This supports
the generally establish contention that ASD patients
tend to have complicated pregnancies[11], which often
involve, upon suspicion, testing for foetal hypoxia. Pre-
sence of hypoxia itself, under the causal models that we
considered, appears to only affect males. This finding is
consistent with our ap r i o r ispecified hypothesis about
greater sensitivity of males to hypoxia-induced insults
during gestation.
We conducted most of our analyses under a strong
assumption that the majority of observed pregnancy and
birth characteristics only affected risk of ASD through
fetal hypoxia. In doing so, we reflected on discussion by
Newschaffer and Cole[25] of testing alternative causal
models in studies of perinatal risk factors in ASD. Since
our entire analysis is predicated on apparent association
of hypoxia with pregnancy and birth characteristics (Z),
we can reject the “etiologic heterogeneity” model[25]: if
hypoxic status was independent of Z we would not have
been able to implement analysis that relies on EM-algo-
rithm. We tested ap r i o rjustified effect modification by
gender and report non-multiplicative interaction on the
basis of stratified analysis. Then we have to consider
“epiphenomena” models [25]. “Epiphenomena model 2”
is in fact represented by Figure 1 and was estimated
here directly. With respect to “epiphenomena model 1”,
it is currently unreasonable to suspect that ASD causes
fetal hypoxia, since that would postulate a fetus that is
both destined to have ASD and able to affects its own
supply of oxygen. This leaves the possibility that “shared
risk factor” model[25] applies and there may be con-
founding by direct effect of elements of Z on risk of
ASD if model in Figure 1 is fitted to the data. We con-
sidered confounding by prematurity: in a stratum of
full-term infants for who we had sufficient sample size
to obtain meaningful estimates (92% of all subjects) we
found little evidence that prematurity induced associa-
tion between hypoxia and ASD. None of the other ele-
ments of Z appeared to be likely candidates for
examining the direct effect on risk of ASD. Of course
given how little we know about causes of ASD, it is pos-
sible that we failed to postulate and test true causal
model. If that is the case, then our estimates may in fact
be biased by latent confounding or effect modification,
which is of course true of most observational research
into subject matters, such as ASD, where uncertainty
abounds about what the actual causes may be.
Missing values are common in public health research.
Understanding the missing mechanism is the key for a
proper missing data analysis. Relaxing unrealistic MAR
assumptions changed the point estimate of the disease-
exposure odds ratio and sifted confidence intervals
(P-values) towards the region conventionally thought of
Table 4 Association of Fetal Hypoxia at Birth1 and
Diagnosis of Autism Spectrum Disorders2: Results of
Logistic Regression Fitted with EM Algorithm for
Handling Unknown Exposures That are Modeled From
Maternal and Birth Characteristics Under Specific NMAR
Assumption Among Full-Term Male Births
Deviation from MAR
3 Strong Strong Moderate Weak
r 0.1 0.2 0.5 0.7
Odds ratio estimate 1.28 1.28 1.24 1.20
95% confidence interval 1.03, 1.60 1.03, 1.58 1.01, 1.52 0.99, 1.46
P-value 0.03 0.03 0.04 0.06
1: at least one of the three tests for fetal hypoxia is positive, i.e. fetal scalp
pH < 7.25, or umbilical artery pH < 7.20, or venous pH < 7.28.
2: singletons born in Alberta 1998-2004 and followed up till March 31, 2008,
effects adjusted for birth year and socio-economic status.
3: contribution of clinical judgment to prescribing the test beyond Z; MAR =
missing at random, r = 1, see Table 3.
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dealing with the special missing value problem in this
project in conjunction with sensitivity analysis using the
specified NMAR assumption altered statistical inference
and was therefore useful.
Conclusions
Our results are consistent with a weak effect of fetal
hypoxia on risk of ASD that is confined to males. It
may well be that some latent indication or an unknown
correlated of testing for hypoxia at birth are responsible
for the increased risk of ASD among males and there-
fore investigation of role of hypoxia at birth in ASD
remains a fruitful area for research.
Additional material
Additional file 1: EM Algorithm with either MAR or NMAR
assumptions. Mathematical details of EM algorithm implemented in this
article.
Additional file 2: Implementation of EM Algorithm for missing
values in SAS software. SAS code that was used to implement EM
algorithm presented in this article with annotation that allow adapting it
to similar applications.
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